270 related articles for article (PubMed ID: 23045665)
1. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
Weikum WM; Oberlander TF; Hensch TK; Werker JF
Proc Natl Acad Sci U S A; 2012 Oct; 109 Suppl 2(Suppl 2):17221-7. PubMed ID: 23045665
[TBL] [Abstract][Full Text] [Related]
2. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
Hanley GE; Brain U; Oberlander TF
Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
[TBL] [Abstract][Full Text] [Related]
3. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
[TBL] [Abstract][Full Text] [Related]
4. Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.
Gurnot C; Martin-Subero I; Mah SM; Weikum W; Goodman SJ; Brain U; Werker JF; Kobor MS; Esteller M; Oberlander TF; Hensch TK
Epigenetics; 2015; 10(5):361-72. PubMed ID: 25891251
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?
Hanley GE; Oberlander TF
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):651-9. PubMed ID: 22733632
[TBL] [Abstract][Full Text] [Related]
6. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
[TBL] [Abstract][Full Text] [Related]
7. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
8. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
[TBL] [Abstract][Full Text] [Related]
10. The effect of perinatal exposures on the infant: antidepressants and depression.
Hanley GE; Oberlander TF
Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
[TBL] [Abstract][Full Text] [Related]
13. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
14. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
[TBL] [Abstract][Full Text] [Related]
15. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
[TBL] [Abstract][Full Text] [Related]
16. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
[TBL] [Abstract][Full Text] [Related]
17. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
18. Prenatal serotonin reuptake inhibitor antidepressant exposure, SLC6A4 genetic variations, and cortisol activity in 6-year-old children of depressed mothers: A cohort study.
Zusman EZ; Chau CMY; Bone JN; Hookenson K; Brain U; Glier MB; Grunau RE; Weinberg J; Devlin AM; Oberlander TF
Dev Psychobiol; 2023 Nov; 65(7):e22425. PubMed ID: 37860904
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
20. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
Nulman I; Rovet J; Stewart DE; Wolpin J; Pace-Asciak P; Shuhaiber S; Koren G
Am J Psychiatry; 2002 Nov; 159(11):1889-95. PubMed ID: 12411224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
